Skip to main content
Premium Trial:

Request an Annual Quote

GeneSpring 7, Signet 5, Cytoscape, Omega 1.8, Inte:Ligand

Premium

Silicon Genetics has released GeneSpring 7 and Signet 5. Enhancements in GeneSpring 7 include new support vector machines, project-based organization, a new Genome Wizard for genome import and management, and a Java API. Signet 5 (formerly called GeNet) now includes a SOAP API, a native Java plug-in API, project-based navigation, and modifiable workspaces.


Version 2.0 of Cytoscape is available at http://www.cytoscape.org. Cytoscape visualizes molecular interaction networks and integrates those interactions with gene expression profiles and other data. New features include the ability to load and save networks in SIF and GML formats, a new open-source graph library, and a new programmer API. Cytoscape is jointly developed by researchers at the Pasteur Institute, the University of California, San Diego, Memorial Sloan-Kettering Cancer Center, and the Institute of Systems Biology.


OpenEye Scientific Software has released Omega 1.8, a software package that generates multi-conformer structure databases for computer-aided drug design. New features include a new distance-bounds method to get better starting structures, and improved ring templates.


Inte:Ligand has launched a new virtual library generation package called ilib diverse. The software builds compounds by combining user-defined fragments. User-adjustable constraints allow a combinatorial approach that provides good structural diversity and fast, automated lead structure modification, according to the company.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more